Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactulose prophylaxis for hepatic encephalopathy in cirrhotic patients with upper gastrointestinal bleeding
TCTR20200526003Phase 4Completed
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lactulose in hepatic encephalopathy (HE), Cirrhosis, upper gastrointestinal bleeding (UGIB), sponsored by None. Started May 2012; status: completed.
02
Drugs
lactulose
03
Conditions
hepatic encephalopathy (HE)Cirrhosisupper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on TCTR20200526003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200526003.